The Long Run with Luke Timmerman
Un pódcast de Timmerman Report
173 Episodo
-
Ep175: Andy Scharenberg on in vivo CAR-T cell therapies
Publicado: 16/3/2025 -
Ep174: Najat Khan on the TechBio Movement
Publicado: 3/3/2025 -
Ep173: Robert Blum on Building a Fully Integrated Biopharma For Muscle Disorders
Publicado: 11/2/2025 -
Ep172: Mostafa Ronaghi on Studying Live Cells at Scale
Publicado: 27/1/2025 -
Ep171: Ram Aiyar on RNA Editing Medicines
Publicado: 13/1/2025 -
Ep170: David Schenkein on Investing in the Future of Biotech
Publicado: 2/1/2025 -
Ep169: Kevin Fitzgerald on the Past & Future of RNAi Medicines
Publicado: 11/12/2024 -
Ep168: Jonathan Bricker on How to Quit Smoking & Prevent Cancer
Publicado: 25/11/2024 -
Ep167: Leslie Williams on transfer RNA therapies
Publicado: 6/11/2024 -
Ep166: Chris Garcia on Engineering Protein Drugs for Cancer, Autoimmunity
Publicado: 15/10/2024 -
Ep165: Zach Hornby on Tackling Cancer Drug Resistance
Publicado: 26/9/2024 -
Ep164: Ted Love and Alan Anderson on Raising the Bar for Sickle Cell Disease Patients
Publicado: 5/9/2024 -
Ep163: Sarah Boyce on RNA Medicines for Muscle Diseases
Publicado: 14/8/2024 -
Ep162: Sean McClain on AI for Biologic Drug Discovery
Publicado: 16/7/2024 -
Ep161: Jeff Stein on a Long-Lasting Flu Drug
Publicado: 1/7/2024 -
Ep160: Abe Ceesay on Precision Neuroscience
Publicado: 17/6/2024 -
Ep159: Jimi Olaghere on Being Functionally Cured of Sickle Cell Disease
Publicado: 3/6/2024 -
Ep158: David Younger and Randolph Lopez on SynBio & AI for Discovery
Publicado: 20/5/2024 -
Ep157: Vineeta Agarwala of A16Z on Investing in AI for Drug Discovery
Publicado: 1/5/2024 -
Ep156: David Liu on New Tools and Techniques for Biology
Publicado: 16/4/2024
"The Long Run" Antarctic explorer Ernest Shackleton would appreciate today's biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something meaningful. Biotech’s relationship with the society that sustains it has never been more tenuous. Join host Luke Timmerman for in-depth, thought-provoking conversations with biotech newsmakers pursuing these great opportunities of the 21st century.
